English
|
Spanish
Supporting oncology professionals through education
Login
Register
The content on this site is intended for healthcare professionals only
Menu
Home
News
Journal
Video
e
learning
Events
Conferences
About us
Keyword
Breast
Prostate & urology
Lung & pleura
Colorectal & gastro
Melanoma & skin
Head & neck
Ovary & gynaecology
Bone
Brain & nervous system
Haematology oncology
Hepatobiliary pancreatic
Paediatric
Neuroendocrine
Sarcomas
News
Latest news
Sign up for news alerts
Submit your news
Explore
Bone
Brain & nervous system
Breast
Colorectal & gastro
Haematology oncology
Head & neck
Hepatobiliary pancreatic
Lung & pleura
Melanoma & skin
Neuroendocrine
Ovary & gynaecology
Paediatric
Prostate & urology
Sarcomas
Journal information
Journal home
Charges
Editorial board
Founding editors
Editor-in-chief
Contact us
Author information
Submit article
Author guidelines
Editorial policies
Copyright information
Why publish with us
Reviewer information
Reviewer guidelines
Memberships
Videos
Recent videos
Sign up
Explore
Bone
Brain & nervous system
Breast
Colorectal & gastro
Haematology oncology
Head & neck
Hepatobiliary pancreatic
Lung & pleura
Melanoma & skin
Neuroendocrine
Ovary & gynaecology
Paediatric
Prostate & urology
Sarcomas
Conferences
Latest conferences
Sign up for latest coverage
Submit your event
About
e
cancer
About
e
cancer
Our founders
Funding statement
Contact us
Home
News
Journal
Video
e
learning
Events
Conferences
About us
Keyword
Breast
Prostate & urology
Lung & pleura
Colorectal & gastro
Melanoma & skin
Head & neck
Ovary & gynaecology
+
-
Bone
Brain & nervous system
Haematology oncology
Hepatobiliary pancreatic
Paediatric
Neuroendocrine
Sarcomas
News
Oncomicrobial vaccines mitigate tumor progression via precisely targeting oncomicrobes in mice
Walking, moving more may lower risk of cardiovascular death for women with cancer history
Revolutionising cancer treatment: targeting EZH2 for a new era of precision medicine
More news +
Videos
Previous
Next
ASCO GU 2025: Latest updates in mRCC
Previous
Next
Challenges of managing patients with NMIBC: from risk stratification to treatment and beyond
Previous
Next
Assessment and management of toxic effects of cancer therapy in elderly patients in Tunisia
Previous
Next
A checklist for designing and reporting cancer drug phase 3 clinical trials
Previous
Next
SABCS 2024: Highlights in breast cancer genomic testing
Previous
Next
Targeted therapies associated with increased risk for and incidence of thrombosis in the treatment of breast cancer
Previous
Next
Patients with early-stage, HR+/HER2-negative BC may benefit from adjuvant T-AC therapy more than from TC
Previous
Next
Post-chemo olaparib continues to improve efficacy in gBRCApv and high-risk, HER2-negative primary breast cancer
Previous
Next
Overview of cancer health disparities: Current state and future directions
Previous
Next
Bladder cancer updates from the second half of 2024
More videos +
e
learning
A multidisciplinary approach to effective management of myelofibrosis
Advancing Pharmacovigilance in Kenya
Urothelial tumours of the urinary tract coding issues
More
e
learning +
Journal
Clinical characteristics and first-line palliative treatment patterns in 3,414 patients with...
Reassessing operability in T4b oral cavity squamous cell carcinoma: a comparative analysis of...
Clinicopathological prognostic factors for survival in patients with breast cancer: a retrospective...
More articles +
e
cancer events (recent)
Hypofractionated Radiotherapy in Practice: Implementation Strategies for Clinical Success
Oct 2024
2nd ecancer Symposium on Sexual and Gender Minorities
Jun 2023
Management of Metastatic Breast Cancer in HR+, HER2- Patients
Apr 2023
Choosing Wisely Nigeria 2023
Mar 2023
More
e
cancer events +
Conferences
Hot Topics in RCC
22 Apr 2024
University of Colorado Cancer Center
17 Jan 2025
ASCO GU 2025
13 Feb 2025
ASCO GI
23 Jan 2025
More events +
More from
e
cancer